Discovery of a Small-Molecule Inhibitor of β-1,6-Glucan Synthesis
- 1 February 2009
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (2), 670-677
- https://doi.org/10.1128/aac.00844-08
Abstract
It is possible that antifungal drugs with novel modes of action will provide favorable options to treat fungal infections. In the course of our screening for antifungal compounds acting on the cell wall, a pyridobenzimidazole derivative with unique activities, named D75-4590, was discovered. During treatment of Saccharomyces cerevisiae with D75-4590, (i) incorporation of [ 14 C]glucose into the β-1,6-glucan component was selectively reduced, (ii) proteins released from the cell had lost the β-1,6-glucan moiety, and (iii) cells tended to clump, resulting in impaired cell growth. Genetic analysis of a D75-4590-resistant mutant of S. cerevisiae indicated that its primary target was Kre6p, which is considered to be one of the β-1,6-glucan synthases. These results strongly suggest that D75-4590 is a specific inhibitor of β-1,6-glucan synthesis. D75-4590 showed potent activities against various Candida species. It inhibited hyphal elongation of C. albicans as well. KRE6 is conserved in various fungi, but no homologue has been found in mammalian cells. These lines of evidence indicate that D75-4590 is a promising lead compound for novel antifungal drugs. To our knowledge, this is the first report of a β-1,6-glucan inhibitor.Keywords
This publication has 47 references indexed in Scilit:
- KEG1/YFR042w Encodes a Novel Kre6-binding Endoplasmic Reticulum Membrane Protein Responsible for β-1,6-Glucan Synthesis in Saccharomyces cerevisiaePublished by Elsevier BV ,2007
- Function of Candida albicans Adhesin Hwp1 in Biofilm FormationEukaryotic Cell, 2006
- Emergence of a Candida krusei Isolate with Reduced Susceptibility to Caspofungin during TherapyAntimicrobial Agents and Chemotherapy, 2006
- Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infectionsInternational Journal of Antimicrobial Agents, 2006
- Seminational Surveillance of Fungemia in Denmark: Notably High Rates of Fungemia and Numbers of Isolates with Reduced Azole SusceptibilityJournal of Clinical Microbiology, 2005
- Multiechinocandin- and Multiazole-ResistantCandida parapsilosisIsolates Serially Obtained during Therapy for Prosthetic Valve EndocarditisAntimicrobial Agents and Chemotherapy, 2005
- Molecular Organization of the Alkali-insoluble Fraction ofAspergillus fumigatus Cell WallPublished by Elsevier BV ,2000
- β‐1,6‐Glucan synthesis in Saccharomyces cerevisiaeMolecular Microbiology, 2000
- A New Water‐soluble Camptothecin Derivative, DX‐8951f, Exhibits Potent Antitumor Activity against Human Tumors in vitro and in vivoJapanese Journal of Cancer Research, 1995
- Glucosylation of chimeric proteins in the cell wall of Saccharomyces cerevisiaeFEBS Letters, 1994